Effects of Hiking at Moderate and Low Altitude on Cardiovascular Parameters in Male Patients With Metabolic Syndrome: Austrian Moderate Altitude Study

Objective Physical activity is a cornerstone in therapy for patients with metabolic syndrome. Walking and hiking in a mountain scenery represents an ideal approach to make them move. The Austrian Moderate Altitude Study (AMAS) 2000 main study is a randomized controlled trial to investigate the cardi...

Full description

Saved in:
Bibliographic Details
Published in:Wilderness & environmental medicine 2014-09, Vol.25 (3), p.329-334
Main Authors: Neumayr, Günther, Fries, Dietmar, Mittermayer, Markus, Humpeler, Egon, Klingler, Anton, Schobersberger, Wolfgang, Spiesberger, Reinhard, Pokan, Rochus, Schmid, Peter, Berent, Robert
Format: Article
Language:English
Subjects:
Adult
Aged
Altitude
Austria
Austrian Moderate Altitude Study
Blood Pressure
cardiovascular parameters
Emergency
Heart Rate
hiking
Humans
Male
metabolic syndrome
Metabolic Syndrome - therapy
Middle Aged
moderate altitude
Time Factors
Walking
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Physical activity is a cornerstone in therapy for patients with metabolic syndrome. Walking and hiking in a mountain scenery represents an ideal approach to make them move. The Austrian Moderate Altitude Study (AMAS) 2000 main study is a randomized controlled trial to investigate the cardiovascular effects of hiking at moderate altitude on patients with metabolic syndrome compared with a control group at low altitude, to assess a potential altitude-specific effect. Methods Seventy-one male patients with metabolic syndrome were randomly assigned to a moderate altitude group (at 1700 m), with 36 participants, or to a low altitude group (at 200 m), with 35 participants. The 3-week vacation program included 12 hiking tours (4 per week, average duration 2.5 hours, intensity 55% to 65% of heart rate maximum). Physical parameters, performance capacity, 24-hour blood pressure, and heart rate profiles were obtained before, during, and after the stay. Results In both groups, we found a significant mean weight loss of −3.13 kg; changes in performance capacity were minor. Systolic, diastolic, and mean arterial pressures and circadian heart rate profiles were significantly reduced in both groups, with no differences between them. Consequently, the pressure-rate product was reduced as well. All study participants tolerated the vacation well without any adverse events. Conclusions A 3-week hiking vacation at moderate or low altitude is safe for patients with metabolic syndrome and provides several improvements in their cardiovascular parameters. The cardiovascular benefits achieved are more likely to be the result of regular physical activity than the altitude-specific effect of a mountain environment.
ISSN:1080-6032
1545-1534
DOI:10.1016/j.wem.2014.01.003